CPVT Electrocardiographic Indices Registry (CEIR)
Welcome to the Catecholaminergic Polymorphic Ventricular Tachycardia Electrocardiographic Indices Registry (CEIR)
Following the success of our multi-national study on Brugada syndrome (BEIR), the team is establishing a similar study on catecholaminergic polymorphic ventricular tachycardia (CPVT). Currently, there is no established predictive model for risk stratification in CPVT. The aim of this project, therefore, is to use different electrocardiographic indices for risk stratification in patients with CPVT.
What is Catecholaminergic Polymorphic Ventricular Tachycardia?
Catecholaminergic ventricular tachycardia (CPVT) is an ion channelopathy characterized by bidirectional VT and typically presents in the first two decades of life. However, as one of the rarest ion channelopathies, data on this disease are limited, especially from underrepresented regions.
What is unique about our project?
We differ from other registries in four major respects:
The investigators are taking an all inclusive stance, and welcome contributions from any interested investigators with relevant data to join our project. For example, we have researchers from all over the globe coming from centres of varying sizes.
We particularly encourage new and junior researchers to join our project.
We have recruited investigators from across the disciplines, such as pre-clinical electrophysiology, data science, clinical cardiology and electrophysiology, and epidemiology, to facilitate collaboration and cooperation.
The goal is to utilize complex and higher dimensional analyses to facilitate risk prediction.
Who are the CEIR investigators?
Canada Investigators
China Investigators
Dr. Xintao Li, MD
Consultant Cardiologist
The First People's Hospital of Changzhou, Changzhou, Jiangsu, People’s Republic of China. 213003
Dr. Fang Zhou Liu, MD, PhD
Consultant Cardiac Electrophysiologist
Guangdong Cardiovascular Institute, Guangdong
People’s Republic of China
Dr. Tong Liu, MD, PhD
Professor of Cardiology
Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease,
Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University,
Tianjin 300211, People’s Republic of China
Dr. Gary Tse, BA (Hons.), MBBS, MA, MPH, MHM, PhD, FESC, FACC, FSCAI, FHRS, FRCP (Glasg, Edin, Lond), FRCPCH, FFPH
Cardiac Electrophysiology Unit, Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration
Reader in Public Health, Kent and Medway Medical School, Kent
United Kingdom
Distinguished Professor, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University
Honorary Professor, Xiamen Cardiovascular Hospital of Xiamen University
Guest Professorship in Cardiovascular Medicine, The First Affiliated Hospital of Dalian Medical University
People’s Republic of China
Dr. Jiandong Zhou
School of Data Science, City University of Hong Kong,
Hong Kong, People’s Republic of China
Greece Investigators
Dr. George Bazoukis, MSc, MD
Second Department of Cardiology,
Laboratory of Cardiac Electrophysiology,
“Evangelismos” General Hospital of Athens,
Athens, Greece
Dr. Konstantinos Letsas, MD, FESC, FEHRA
Consultant Cardiologist
Second Department of Cardiology,
Laboratory of Cardiac Electrophysiology,
“Evangelismos” General Hospital of Athens,
Athens, Greece
India Investigators
Dr. Manlio F. Márquez Murillo
Instituto Nacional de Cardiología “Ignacio Chávez”
Mexico City, Mexico
Dr. Jorge Francisco Herrera Orozco
Instituto Nacional de Cardiología “Ignacio Chávez”
Mexico City, Mexico
Dr. Ramon Alexander Hernandez Dominguez
Instituto Nacional de Cardiología “Ignacio Chávez”
Mexico City, Mexico
Dr. Bernardo Wise, MD
Associate Professor and Cardiac Electrophyisiologist
Christus Muguerza AE Hospital
Monterrey, Mexico
Nevetherlands Investigators
Dr. Natasja M.S. de Groot, MD, PhD
Professor of Cardiology
Cardiologist/Electrophysiologist, Chief of Translational Electrophysiology Unit
Erasmus MC, Rotterdam, Netherlands
Poland Investigators
Dr. Marek Jastrzebski, MD, PhD
First Department of Cardiology and Electrocardiology, Jagiellonia University, Collegium Medicum
Kraków, Poland
Dr. Pawel Matusik, MD, PhD
Institute of Cardiology, Jagiellonian University Medical College and the John Paul II Hospital,
Kraków, Poland
Russia Investigators
Dr. Elena Zaklyazminskaya, MD, PhD
Professor and Head of Medical Genetics Laboratory
Petrovsky Russian Research Centre of Surgery 2,
Abricosovsky per., 119991 Moscow, Russia
Saudi Arabia Investigators
Dr. Enes Elvin Gul, MD, FESC, FEHRA
Department of Cardiology,
Istanbul Medipol University, Istanbul, Turkey
Switzerland Investigators
Dr. Giulio Conte, MD, PhD
Senior Electrophysiologist - Division of Cardiology, Fondazione
Cardiocentro Ticino, Lugano, Switzerland
Privat Dozent - Università della Svizzera Italiana, Lugano, Switzerland
Clinical Scientist – Centre for Computational Medicine in Cardiology (CCMC),
Università della Svizzera Italiana, Lugano, Switzerland
Turkey Investigators
Dr. Göksel Çinier, MD
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center,
Istanbul, Turkey
Dr. Levent Pay, MD
Cardiologist
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Surgery Hospital
Turkey
United Kingdom Investigators
Dr. Kamalan Jeevaratnam, DAHP, DVM, MMedSc (Mal), PhD (Cambridge), MRCVS (UK)
Head of Department of Pre-clinical Sciences,
Faculty of Health and Medical Sciences,
University of Surrey
Guildford, United Kingdom